MedTrace Logo

Treatment Outcome and Prognostic Factors for Rheumatoid Arthritis (RA) Patients With Interstitial Lung Disease (ILD)

NCT03099525 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2020-06-17

No results posted yet for this study

Summary

The objectives of this single center, prospective, non-interventional cohort is to understand patient characteristics, general treatment patterns, effectiveness/safety of conventional disease modifying antirheumatic drug (DMARD) and biologic DMARD treatments in rheumatoid arthritis patients with ILD in the real-world setting

Conditions

Interventions

OTHER

ILD

This is an observational study without any intervention.

Sponsors & Collaborators

  • Hanyang University

    lead OTHER

Principal Investigators

  • Yoon-Kyoung Sung, MD,PhD,MPH · Hanyang University Hospital for Rheumatic Diseases

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2021-03-31
Completion
2022-03-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03099525 on ClinicalTrials.gov